Clinical Trials Sponsored by Chiesi España

Total 5523 results

Sociedad Española de Oncología Quirúrgica
Sysmex España

Unknown

Validation of Ferromagnetic Tracer in Melanoma Sentinel Node (IMINEM)

Sentinel Lymph Node | Melanoma Stage

Spain
Academia Española de Nutrición y Dietética
LIDL España

Completed

Preparation of Complementary Feeding in Spain: a Cross-sectional Study

Complementary Feeding | Infant Nutritional Physiological Phenomena

Spain
Hospital San Carlos, Madrid
Philips Respironics; Chiesi España

Completed

Safety of Mechanical Insufflation-exsufflation and Hypertonic Saline (SMASH)

Tracheostomy | Endotracheal Tube

Spain
Roxall Medicina España S.A

Recruiting

Study to Evaluate the Safety of Treatment With A"LLERGOVAC® HIMENÓPTEROS" in Patients Sensitized to This Venom (HIPNOS)

Allergy to Himenoptera Venom

Spain
Roxall Medicina España S.A

Completed

Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense

Allergic Rhinoconjunctivitis

Spain, Portugal
Roxall Medicina España S.A

Completed

A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea

Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites

Allergic Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica

Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense

Allergic Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

Study to Evaluate the Efficacy and Safety of "Allergovac Poliplus" in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Asthma (ARES)

Rhinitis, Allergic | Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT)

Allergic Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract

Allergic Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

A Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Olea Europaea and Phleum Pratense

Rhinoconjuntivitis

Spain
Roxall Medicina España S.A

Completed

Biological Standardization of D. Glomerata, L. Perenne, S. Cereale and O. Europaea Pollen Extracts

Sensitization to Allergens

Spain
Roxall Medicina España S.A

Completed

Determination of Biological Activity of Three Allergen Extracts

Hypersensitivity

Spain
Roxall Medicina España S.A

Completed

Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice (APOLO)

Asthma | Allergic Rhinitis | Rhinoconjunctivitis

Spain
Roxall Medicina España S.A

Completed

Study for Evaluating Life Quality in Patients With Rhinoconjunctivitis (ÍCARA)

Allergic Rhinoconjunctivitis

Spain
University of Extremadura
Ministerio de Asuntos Economicos y Transformación Digital, España; Junta de...

Completed

Effects of tDCS on People With Fibromyalgia

Fibromyalgia

Spain
Roxall Medicina España S.A
University Hospital, Zürich

Completed

Biological Standardization of Allergen Extracts of Pollens of Betula Pendula, Phleum Pratense and Mite Extract of Dermatophagoides Pteronyssinus

Allergy

Switzerland
Grupo Español de Rehabilitación Multimodal
REDGERM; Sociedad Española de Cirugía de la Obesidad

Unknown

Postoperative Outcomes Within an Enhanced Recovery After Bariatric Surgery Protocol (POWER3)

Postoperative Complications | Bariatric Surgery Candidate | Perioperative Care

Spain
Espace Hogan

Unknown

Psychotherapy and Pharmacotherapy in Dissociative Disorders

Dissociative Disorders

Switzerland
Hospital de Sagunto
Biopolis S.L.; Laboratorios Heel España

Unknown

Changes in Viral Load in COVID-19 After Probiotics

COVID-19

Spain
Chiesi Hungary Ltd.
Chiesi Slovenija, d.o.o.; CHIESI Bulgaria Ltd.; CHIESI CZ s.r.o.

Recruiting

NEXThaleR Real-world Study Assessing the EffectivenesS of BDP/FF/G Fixed triPle cOmbiNation on Symptom scorEs in COPD Patients (RESPONSE)

COPD

Hungary
Chiesi Italia

Completed

Global Burden and Treatment Trajectiories in Italian Patients With Fabry Disease (GROUND)

Fabry Disease

Italy
Chiesi Italia

Completed

Triple Therapy in Real-life: Impact on Adherence and Health Status (TRITRIAL)

COPD

Italy
Chiesi Italia

Active, not recruiting

Effects of Beclometasone Dipropionate/Formoterol Fumarate Via NEXT(Haler) in a Real-world Study on Asthma Control (NEWTON)

Asthma

Italy
Hospital Universitari Vall d'Hebron Research Institute
Sysmex España S.L.

Unknown

Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment. (SENTINAC-01)

Breast Cancer

Spain
Bolton Medical
Bolton Medical Espana SLU

Terminated

An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft

Aortic Aneurysm, Abdominal

Spain, Belgium, Netherlands, Germany, Italy, Switzerland, United Kingdom
Universidad San Jorge
Mutua MAZ; BSH electrodomésticos España S.A.

Completed

Prevention and Treatment of Chronic Low Back Pain Through an Adapted Exercise Program

Low Back Pain

Spain
Escala Medical LTD

Completed

Evaluation of Safety and Efficacy of the Apyx™ Device for the Repair of Pelvic Organ Prolapse (POP)

Pelvic Organ Prolapse

Israel
Chiesi Farmaceutici S.p.A.

Completed

Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase (CT04 POLEP)

Alzheimer's Disease

United States, Italy
Chiesi Farmaceutici S.p.A.

Completed

Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Open Label Extension (CT04 OLEP)

Alzheimer's Disease

United States, Italy
Chiesi Farmaceutici S.p.A.
Chiesi USA, Inc.

Completed

Dose Finding Study of CHF 4226 for Treating Patients With COPD

Chronic Obstructive Pulmonary Disease

United States, Czech Republic, Germany, Poland, Romania, South Africa
Chiesi Hungary Ltd.
Chiesi Slovenija, d.o.o.

Recruiting

Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients (LTA)

Liver Failure

Hungary, Slovenia
Chiesi Farmaceutici S.p.A.
Chiesi USA, Inc.

Available

Open-Label Expanded Access Treatment With Pegunigalsidase Alfa for Fabry Disease Patients

Fabry Disease

United States
Fundacion Profesor Novoa Santos
ODDS , S.L.; Vifor Pharma España, S.L.

Completed

Feasibility of Implementation of Recommended Standards in Patients With Heart Failure (HFOutcomesSP)

Heart Failure

Spain
Sociedad Española de Trasplante

Completed

Variability of Hemoglobin Levels After Kidney Transplantation

Renal Anemia

Spain
Hospital Español de Mexico

Withdrawn

Vitamin C to Reduce Vasopressor Dose in Septic Shock (ViCiS)

Sepsis | Septic Shock

Mexico
Asociación Española de Gastroenterología

Completed

Stress and Personality Profiles in IBD

Inflammatory Bowel Disease

Spain
Asociación Española de Gastroenterología

Completed

Diagnostic Accuracy of NICE Classification to Predict Deep Submucosal Invasion (NICE)

Colonic Polyps

Spain
Asociación Española de Esclerodermia

Completed

Stress, Scleroderma and Quality of Life

Scleroderma

Spain
Asociación Española de Gastroenterología

Active, not recruiting

European Polyp Surveillance Trial (EPoS)

Colorectal Neoplasms

Spain
Grupo Espanol Multidisciplinario del Cancer Digestivo
Merk Sharp & Dohme España S.A.

Recruiting

Pembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC). (PEMBROLA)

Metastatic Colorectal Cancer

Spain
Universidad de León
Consejo General de Colegios Oficiales de Enfermería España

Active, not recruiting

Polymorphism of ApoE in Alzheimer's Disease: Genetic Study in Castile and Leon (Spain)

Alzheimer Disease

Spain
Chiesi UK
Liverpool Heart and Chest Hospital NHS Foundation Trust

Completed

Non-interventional Study Related to Fixed LAMA/LABA/ICS Triple Therapy (TriOptimize)

COPD

United Kingdom
Chiesi Farmaceutici S.p.A.

Recruiting

PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI) (TRIBE)

Chronic Obstructive Pulmonary Disease

United Kingdom
Chiesi Farmaceutici S.p.A.

Recruiting

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR) (PILLAR)

Chronic Obstructive Pulmonary Disease

Bulgaria, United States, Argentina, Austria, Bosnia and Herzegovina, Chile, Croatia, Czechia, Estonia, Germany, Greece, Hungary, Israel, Latvia, Mexico, Netherlands, New Zealand, North Macedonia, Poland, Romania, Russian Federation and more
Chiesi Farmaceutici S.p.A.

Recruiting

A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (TRITON)

COPD | COPD Exacerbation

United States, Bulgaria, Hungary, Poland, Argentina, Czechia, Mexico, Canada, Puerto Rico, Romania
Chiesi Farmaceutici S.p.A.

Active, not recruiting

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF

Idiopathic Pulmonary Fibrosis

North Macedonia, Ukraine, United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Study in Adult Patients With Moderate to Severe Asthma (FEEL)

Asthma

Italy

3

Subscribe